{"transactions":[{"id":849504,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:17:22.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":25640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date."}],"balance_after":25640,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":25640},"source":{"system":"sec-edgar","filing":"0001104659-26-026586","document":"tm268588-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026586/tm268588-4_4seq1.xml","form_type":"4"}},{"id":1279282,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:20:10.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date."}],"balance_after":54343,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-25-010564","document":"tm255864-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010564/tm255864-6_4seq1.xml","form_type":"4"}},{"id":1573490,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:05:15.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date."}],"balance_after":94009,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-24-035732","document":"tm249071-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035732/tm249071-4_4seq1.xml","form_type":"4"}},{"id":1573489,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:05:15.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":39666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024."}],"balance_after":39666,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":39666},"source":{"system":"sec-edgar","filing":"0001104659-24-035732","document":"tm249071-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035732/tm249071-4_4seq1.xml","form_type":"4"}},{"id":1700429,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-27T02:54:29.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":10461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests immediately prior to the Company's 2024 annual shareholders meeting."}],"balance_after":10461,"derivative":{"exercise_price":2.39,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":10461},"source":{"system":"sec-edgar","filing":"0001104659-23-129368","document":"tm2333426-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129368/tm2333426-2_4seq1.xml","form_type":"4"}},{"id":2296618,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T19:50:29.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":5.11,"expiration_date":"2032-04-13","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-22-046446","document":"tm2212851-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465922046446/tm2212851-4_4seq1.xml","form_type":"4"}},{"id":2676435,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T20:26:17.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":28000,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-21-078787","document":"tm2119245-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465921078787/tm2119245-3_4seq1.xml","form_type":"4"}},{"id":2952422,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:11:27.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":3.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001104659-20-133643","document":"tm2038059-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920133643/tm2038059-10_4seq1.xml","form_type":"4"}},{"id":3512532,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-25T01:30:29.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":27383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant."}],"balance_after":27383,"derivative":{"exercise_price":3.15,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":27383},"source":{"system":"sec-edgar","filing":"0001144204-19-028257","document":"tv522363_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000114420419028257/tv522363_4.xml","form_type":"4"}},{"id":4359510,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":61587,"kind":"person","name":"PATTI JOSEPH M","position":1,"cik":"0001283215","reported_name":"PATTI JOSEPH M","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-05T17:09:14.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":650000,"price":0.656,"value":426400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests as follows:  33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018."}],"balance_after":2113304,"derivative":{"exercise_price":0.656,"exercise_date":"2017-10-03","expiration_date":"2027-04-03","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001437749-17-006117","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774917006117/rdgdoc.xml","form_type":"4"}}]}